Dr. Christian Ruff joins the podcast to discuss Factor XI inhibition and his recent Late-Breaking Clinical Trial presentation at AHA, the AZALEA-TIMI 71 trial.
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School